Sector News

Vertellus completes acquisition of specialty ingredients businesses from Chemtrade

November 7, 2021
Chemical Value Chain

Vertellus, a manufacturer of specialty products for various consumer goods, food & agriculture, healthcare, and industrial markets, today announced the completion of its acquisition of certain businesses of Chemtrade Logistics Income Fund (TSX: CHE.UN) (“Chemtrade”) responsible for producing potassium chloride, caustic pellets, and vaccine adjuvants.

The acquired businesses give Vertellus a leading market position in the manufacturing of specialty ingredients that are essential in the efficacy of medications for hypertension and diabetes, production of next-generation biologics, and improving the effectiveness of certain vaccines. This acquisition expands Vertellus’ capabilities to manufacture and develop specialty ingredients in the dynamic healthcare and pharmaceutical sectors, reach an expanding global base of long-term customers, and strengthen its portfolio in these market segments.

John Van Hulle, CEO of Vertellus, said, “We are thrilled to welcome these strong Chemtrade businesses to the Vertellus family as we further extend our reach in the high-growth healthcare and pharmaceutical sectors. Our team at Vertellus continues to identify growth-focused opportunities and partnerships to expand our capabilities and serve our customers.”

Indianapolis-based Vertellus is owned by Pritzker Private Capital and management.

By Vertellus, Press Release

Source: vertellus.com

comments closed

Related News

October 2, 2022

Trinseo announces potential closure of Boehlen, Germany Styrene Plant

Chemical Value Chain

Trinseo (NYSE: TSE), a specialty material solutions provider, announced it has initiated an information and consultation process with the Works Council of Trinseo Deutschland GmbH regarding the potential closure of its styrene monomer production site in Boehlen, Germany.

October 2, 2022

Celeste Mastin appointed H.B. Fuller President and CEO, succeeding Jim Owens upon his retirement

Chemical Value Chain

H.B. Fuller Company announced that Celeste Mastin, Executive Vice President and Chief Operating Officer, will succeed Jim Owens as H.B. Fuller’s President and Chief Executive Officer, effective December 4, 2022. Upon assuming the role, Mastin will also join the Company’s Board of Directors, replacing Owens, who will be retiring.

October 2, 2022

LyondellBasell realigns executive team, forms circular and low-carbon solutions business

Chemical Value Chain

New LyondellBasell CEO Peter Vanacker, who joined the company from Neste in May, today named his senior executive team and outlined organizational changes, including creation of a circular and low-carbon solutions business. All changes will be effective 1 October.